Tuesday, December 29, 2020

Zydus Cadila receives DCGI nod for NAFLD drug in India

Zydus Cadila receives DCGI nod for NAFLD drug in India The Drug Controller General of India (DCGI) has approved the new drug application (NDA) for Saroglitazar Mg for the treatment of non-alcoholic fatty liver disease (NAFLD) in India, Zydus Cadila said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2MjQTfu
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Small and midcap stocks may face volatility, but long-term returns still strong: Vikas Khemani

​Every day there was some negative news flow, global concern, geopolitical concern, inflation concern, oil prices, commodity, everything was...